New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Editor's Top Picks
AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study
A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in…
Submit Your Paper →
More form New Studies
Sleep loss triggers simultaneous damage across seven body systems, new evidence shows
Controlled studies show that restricting sleep to 4–6 hours per night for one week triggers…
Why the ‘2pm coffee cutoff’ is a myth: genetics and lifestyle create a 15-fold range in caffeine metabolism
A new systematic review reveals that caffeine half-life varies 15- to 40-fold across healthy adults,…
Resistant Starch and Gut Health: Why Fiber Type Matters More Than You Think
Resistant starch works through a specific bacterial fermentation pathway that other fibers do not, requiring…
The 30-gram protein myth: why recent evidence challenges the fitness industry’s most durable claim
For over a decade, the fitness industry has promoted a rule: your body can only…
Why Thiamine Deficiency Is Silent but Serious in Heart Failure Patients
Loop diuretics—the standard treatment for heart failure—deplete thiamine, the essential cofactor for energy production. Research…